Level Bio AB (XSAT:LEVBIO) Total Liabilities : kr7.78 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Total Liabilities?

Level Bio AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr7.78 Mil.

Level Bio AB's quarterly Total Liabilities increased from Sep. 2023 (kr6.83 Mil) to Dec. 2023 (kr8.68 Mil) but then declined from Dec. 2023 (kr8.68 Mil) to Mar. 2024 (kr7.78 Mil).

Level Bio AB's annual Total Liabilities declined from Dec. 2021 (kr9.95 Mil) to Dec. 2022 (kr8.91 Mil) and declined from Dec. 2022 (kr8.91 Mil) to Dec. 2023 (kr8.68 Mil).

Level Bio AB Total Liabilities Historical Data

The historical data trend for Level Bio AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Total Liabilities Chart

Level Bio AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

7.31

6.90

9.95

8.91

8.68

Level Bio AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															6.66	6.26	6.83	8.68	7.78

Level Bio AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Level Bio AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.026	+	(0	+	0.652
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	8.68

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	19.093	-	10.415
	=	8.68

Level Bio AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.193	+	(0	+	0.584
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.78

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	15.737	-	7.96
	=	7.78

Level Bio AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Level Bio AB (XSAT:LEVBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

LEVBIO:Sweden

Address

Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30

Website

http://www.alphahelix.com

AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines